![](/media-library/header-images/istock-1952703843.x32afadbf.jpg?w=500&h=500&fit=crop&q=80&f=webp)
PEPITEM – a novel protective agent for inflammageing
A naturally occurring peptide could potentially rejuvenate the immune response in older individuals and protect against 'inflammageing'.
- Published: 18 July 2024
Cutting-edge research and insightful commentary from world-leading experts.
Filter
44 results were found based on your search term
A naturally occurring peptide could potentially rejuvenate the immune response in older individuals and protect against 'inflammageing'.
Monitoring using consumer wearable devices was found to have clinical value for comparing response to two treatments for atrial fibrillation and heart failure
A wider group of patients with atrial fibrillation than previously thought are at risk of stroke, blood clots, vascular dementia and death
An analysis of data from over 16,700 patients reveals that ethnic minority patients with heart failure are at much higher risk of death than white patients.
Patients with Atrial Fibrillation deemed high risk following analysis had five times as many cardiovascular events as low-risk cluster
Procedure used to treat children born with heart conditions may provide a new treatment opportunity
Team led by Dr Katja Gehmlich wins half a million pound grant to further understanding of condition called hypertrophic cardiomyopathy
Fabry disease screening to be improved working with community groups